AI as a portfolio and operational tool in Asia
How does a major private equity firm actually embed AI into its investment process — and what does that look like in practice across Asia's heavily regulated sectors? Ganen Sarvananthan traces TPG's journey from using AI as an internal tool in 2019 to deploying a dedicated engineering team focused on portfolio value creation today. But when it comes to healthcare AI in Asia, will government regulation accelerate or block adoption? The radiology case study reveals just how complex the answer is.